Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03996707
Other study ID # 2019-124JH
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date July 29, 2019
Est. completion date July 15, 2021

Study information

Verified date September 2021
Source Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of this study is to determine whether immediate weight-bearing following foot and ankle surgery provides similar or superior results to the traditional non-weight-bearing post-operative course, while reducing the disuse atrophy and length of rehabilitation necessary to recover during the transition to weight-bearing following an extended course of non-weight-bearing. This will be done by way of clinical follow-up, serial radiographs and/or other appropriate imaging modalities, and patient reported outcomes by way of AOFAS and SF-36 surveys.


Description:

The study is a randomized 1:1, controlled trial, prospective in nature, where participants undergoing foot and ankle surgery will be randomly placed into one of two groups; an immediate weight-bearing group or a non-weight-bearing group. The patients will be randomly placed into the study group and control group if they meet all eligibility criteria. This study will be conducted at 5 investigative clinic sites; West Penn Hospital, Forbes Regional Hospital, Jefferson Regional Hospital, Bethel Park Surgery Center, and Monroeville Surgery. Recruitment will stop when a minimum of 230 subjects are consented. The study duration will require 7 visits to the clinic plus a surgery day therefore will require a pre-surgical visit/screening, surgery procedural day and six outpatient post-operative visits to the clinics. The entire follow up period will occur over 2 years.


Recruitment information / eligibility

Status Terminated
Enrollment 5
Est. completion date July 15, 2021
Est. primary completion date July 15, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 89 Years
Eligibility Inclusion Criteria: 1. Males or females age 18 to 89 years 2. Undergoing foot and ankle surgery 3. Must be able to read and understand English and consent for themselves Exclusion Criteria: 1. Diagnosed peripheral neuropathy 2. Diagnosed peripheral vascular disease 3. Documented infection to the surgical extremity 4. Previous surgery to the surgical limb 5. Laboratory abnormalities that indicate clinically significant hematologic, hepatobiliary, or renal disease which would predispose patients to poor healing and/or non-union 6. Subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Weight Bearing
Immediate protected weight bearing in a CAM walking boot following foot & ankle surgery
Strict non-weight bearing
Strict non weight bearing for 6 weeks following foot & ankle surgery

Locations

Country Name City State
United States Steel Valley Orthopaedic and Sports Medicine Clairton Pennsylvania
United States The Foot & Ankle Institute/Western Pennsylvania Hospital Pittsburgh Pennsylvania

Sponsors (1)

Lead Sponsor Collaborator
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot. Pain, Function, Alignment Score 0-100, 100 being most healthy Both Arms: Screening
Primary Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot. Pain, Function, Alignment Score 0-100, 100 being most healthy Both Arms: Post-operative 6-8 weeks
Primary Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot. Pain, Function, Alignment Score 0-100, 100 being most healthy Both Arms: Post-operative 3 month
Primary Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot. Pain, Function, Alignment Score 0-100, 100 being most healthy Both Arms: Post-operative 12 month
Primary Safety/Tolerability/Quality of Life/Satisfaction:Both Patient & Physician Assessment - American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale American Orthopaedic Foot and Ankle Score (AOFAS) Ankle-Hindfoot Scale as it pertains to the patient's ankle/foot. Pain, Function, Alignment Score 0-100, 100 being most healthy Both Arms: Post-operative 24 month
Primary Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND 36 Item Short Form Survey (SF36) RAND. 8 scaled scores, 0-100, 100 being most healthy Both Arms: Screening
Primary Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND 36 Item Short Form Survey (SF36) RAND. 8 scaled scores, 0-100, 100 being most healthy Both Arms: Post-operative 6-8 weeks
Primary Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND 36 Item Short Form Survey (SF36) RAND. 8 scaled scores, 0-100, 100 being most healthy Both Arms: Post-operative 3 month
Primary Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND 36 Item Short Form Survey (SF36) RAND. 8 scaled scores, 0-100, 100 being most healthy Both Arms: Post-operative 12 month
Primary Quality of Life/Satisfaction:Patient Report Outcome - 36 Item Short Form Survey (SF36) RAND 36 Item Short Form Survey (SF36) RAND. 8 scaled scores, 0-100, 100 being most healthy Both Arms: Post-operative 24 month
Secondary Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation. Both arms: Screening
Secondary Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation. Both arms: Post-operative 2-3 weeks
Secondary Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation. Both arms: Post-operative 6-8 weeks
Secondary Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation. Both arms: Post-operative 3 month
Secondary Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation. Both arms: Post-operative 6 month
Secondary Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation. Both arms: Post-operative 12 month
Secondary Secondary Outcome: Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing osseous healing both clinical and radiographic evaluation. Both arms: Post-operative 24 month
Secondary Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures. Both arms: Screening
Secondary Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures. Both arms: Post-operative 2-3 weeks
Secondary Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures. Both arms: Post-operative 6-8 weeks
Secondary Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures. Both arms: Post-operative 3 month
Secondary Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures. Both arms: Post-operative 6 month
Secondary Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures. Both arms: Post-operative 12 month
Secondary Safety/Efficacy/Tolerability - Frequency of complications during the perioperative and post-operative periods Frequency of complications during the perioperative and post-operative periods, measured by assessing healing outcomes of soft tissue procedures. Both arms: Post-operative 24 month
See also
  Status Clinical Trial Phase
Completed NCT04294732 - Efficacy of Popliteal Block and Bupivacaine Concentration Used for Analgesia in Foot and Ankle Surgery Phase 4